Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Equillium, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q3 2025
- Shares held
- 35.3M
- +7.46M (+26.8%) vs. Q3 2025
- Total value
- $54.7M
- +$14.9M (+37.4%) vs. Q3 2025
- New holders
- 8
- 15 more added
- Sold out
- 11
- 7 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 5,862,212 | $9.06M | 0.00% | +5,862,212 | New |
| ADAR1 Capital Management, LLC | 5,608,078 | $8.69M | 0.65% | +48,090+0.9% | Added |
| Adage Capital Partners GP, L.L.C. | 5,329,416 | $8.26M | 0.01% | 00.0% | Unchanged |
| Decheng Capital LLC | 4,447,308 | $6.89M | 0.93% | 00.0% | Unchanged |
| Woodline Partners LP | 3,500,901 | $5.43M | 0.02% | −7,870−0.2% | Reduced |
| Standard Life Aberdeen plc | 2,366,688 | $3.67M | 0.01% | +1,987,162+523.6% | Added |
| Balyasny Asset Management LLC | 2,076,250 | $3.22M | 0.01% | +72,602+3.6% | Added |
| Vanguard Group Inc | 1,920,423 | $2.98M | 0.00% | +606,477+46.2% | Added |
| Renaissance Technologies LLC | 733,226 | $1.14M | 0.00% | +118,303+19.2% | Added |
| Cantor Fitzgerald, L. P. | 562,643 | $872.1K | 0.03% | +137,643+32.4% | Added |
| Hudson Bay Capital Management LP | 428,538 | $664.2K | 0.00% | +150,000+53.9% | Added |
| Diadema Partners LP | 347,393 | $538.5K | 0.32% | +47,393+15.8% | Added |
| Geode Capital Management, LLC | 345,310 | $535.3K | 0.00% | +34,491+11.1% | Added |
| Two Sigma Investments, LP | 324,610 | $503.1K | 0.00% | +191,606+144.1% | Added |
| Ikarian Capital, LLC | 303,555 | $470.5K | 0.06% | −28,742−8.6% | Reduced |
| Susquehanna International Group, LLP | 185,669 | $287.8K | 0.00% | +185,669 | New |
| State Street Corp | 155,420 | $240.9K | 0.00% | +17,900+13.0% | Added |
| BlackRock, Inc. | 126,053 | $195.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 100,850 | $156.3K | 0.00% | +100,850 | New |
| Boothbay Fund Management, LLC | 93,211 | $144.5K | 0.00% | −28,742−23.6% | Reduced |
| Persistent Asset Partners Ltd | 93,123 | $144.3K | 0.07% | +24,132+35.0% | Added |
| Northern Trust Corp | 88,529 | $137.2K | 0.00% | +53,510+152.8% | Added |
| Royal Bank of Canada | 79,734 | $124.0K | 0.00% | +79,734 | New |
| AlphaCore Capital LLC | 52,345 | $81.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 44,100 | $68.4K | 0.00% | +44,100 | New |
| Morgan Stanley | 35,734 | $55.4K | 0.00% | +25,649+254.3% | Added |
| Schonfeld Strategic Advisors LLC | 25,381 | $39.3K | 0.00% | −99,442−79.7% | Reduced |
| Tudor Investment Corp Et Al | 20,100 | $31.2K | 0.00% | +20,100 | New |
| Apollon Wealth Management, LLC | 13,875 | $21.5K | 0.00% | 00.0% | Unchanged |
| Coastal Bridge Advisors, LLC | 10,500 | $16.3K | 0.00% | +10,500 | New |
| Tower Research Capital LLC (TRC) | 4,070 | $6.31K | 0.00% | −2,336−36.5% | Reduced |
| Wells Fargo & Company | 1,000 | $1.55K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 920 | $1.43K | 0.00% | −27,110−96.7% | Reduced |
| Bank of America Corp | 295 | $457 | 0.00% | +21+7.7% | Added |
| SBI Securities Co., Ltd. | 283 | $439 | 0.00% | −162−36.4% | Reduced |
| Jones Financial Companies LLLP | 250 | $388 | 0.00% | +250 | New |
| StemPoint Capital LP | 0 | $0 | 0.00% | −1,908,935−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −85,557−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −41,220−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −39,739−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −28,300−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,356−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,779−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,544−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,922−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −263−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Takeda Pharmaceutical Co Ltd | – | – | – | – | Not filed |